Delaware District Court
Case #: 1:25-cv-00498
Nature of Suit835 Property Rights - Patent – Abbreviated New Drug Application
Cause35:271 Patent Infringement
Case Filed:Apr 24, 2025
Last checked: Thursday Apr 24, 2025 4:07 PM EDT
Defendant
Granules Pharmaceuticals, Inc.
Plaintiff
Tris Pharma, Inc.
Represented By
Alexandra M. Joyce
Mccarter & English, LLP
contact info
Daniel M. Silver
Mccarter & English, LLP
contact info


Docket last updated: 04/25/2025 11:59 PM EDT
Thursday, April 24, 2025
6 6 misc Patent/Trademark Report to Commissioner of Patents Fri 04/25 10:41 AM
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,590,081. (mpb)
Related: [-]
5 5 service Summons Issued Thu 04/24 3:37 PM
Summons Issued as to Granules Pharmaceuticals, Inc. on 4/24/2025. (mpb)
Related: [-]
4 4 misc Disclosure Statement - Rule 7.1 Thu 04/24 3:36 PM
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Tris Pharma, Inc. (mpb)
Related: [-]
3 3 misc ANDA Form Thu 04/24 3:35 PM
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/12/2025. Date of Expiration of Patent: 9/24/2038. Thirty Month Stay Deadline: No earlier than 9/12/2027. (mpb) Modified on 4/24/2025 (nms)
Related: [-]
2 2 misc Magistrate Consent Forms Thu 04/24 3:33 PM
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb)
Related: [-]
1 1 8 pgs cmp Complaint Thu 04/24 3:33 PM
COMPLAINT for Patent Infringement against Granules Pharmaceuticals, Inc. (Filing fee $ 405, receipt number ADEDC-4669579) - filed by Tris Pharma, Inc.(mpb)
Related: [-]
Att: 1 Exhibit A,
Att: 2 Civil Cover Sheet